ArticleFrontiers in immunology2022

Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.

Federica Dominelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.